[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2013/102242,2013,A1Locationinpatent:Page/Pagecolumn93
[2]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]
[3]Liu,Zhi-Yun;Wen,Zhi-Hui;Wang,Xiao-Chen[AngewandteChemie-InternationalEdition,2017,vol.56,#21,p.5817-5820][Angew.Chem.,2017,vol.129,p.5911-5914,4]
[4]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]
[5]CurrentPatentAssignee:SANOFI-US4069256,1978,ACurrentPatentAssignee:SANOFI-US4216326,1980,ACurrentPatentAssignee:SANOFI-US4308382,1981,A
[1]Walters;McElvain[JournaloftheAmericanChemicalSociety,1933,vol.55,p.4625,4626]
[2]Tschitschibabin[ChemischeBerichte,1903,vol.36,p.2711]
[1]Ding,CharlesZ.;Rovnyak,GeorgeC.;Misra,RajN.;Grover,GaryJ.;Miller,ArthurV.;Ahmed,SyedZ.;Kelly,Yolanda;Normandin,DianeE.;Sleph,PaulG.;Atwal,KarnailS.[JournalofMedicinalChemistry,1999,vol.42,#18,p.3711-3717]
[1]Ablordeppey,SethY;Fischer,JamesB;Law;Glennon,RichardA[Bioorganicandmedicinalchemistry,2002,vol.10,#8,p.2759-2765]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists.
Journal: Bioorganic & medicinal chemistry letters 20080115
Title: Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
Journal: Journal of medicinal chemistry 20050324
Title: Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
Journal: Bioorganic & medicinal chemistry letters 20040405
